Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. (Q30352594)

20 June 2017

Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis. (English)

1 reference

20 June 2017

0 references

Pablo Bifani

2

0 references

Mary Jackson

object named as

Mary Jackson

14

0 references

author name string

Kevin Pethe

1

1 reference

20 June 2017

Jichan Jang

3

1 reference

20 June 2017

Sunhee Kang

4

1 reference

20 June 2017

Seijin Park

5

1 reference

20 June 2017

Sujin Ahn

6

1 reference

20 June 2017

Jan Jiricek

7

1 reference

20 June 2017

Juyoung Jung

8

1 reference

20 June 2017

Hee Kyoung Jeon

9

1 reference

20 June 2017

Jonathan Cechetto

10

1 reference

20 June 2017

Thierry Christophe

11

1 reference

20 June 2017

Honggun Lee

12

1 reference

20 June 2017

Marie Kempf

13

1 reference

20 June 2017

Anne J Lenaerts

15

1 reference

20 June 2017

Ha Pham

16

1 reference

20 June 2017

Victoria Jones

17

1 reference

20 June 2017

Min Jung Seo

18

1 reference

20 June 2017

Young Mi Kim

19

1 reference

20 June 2017

Mooyoung Seo

20

1 reference

20 June 2017

Jeong Jea Seo

21

1 reference

20 June 2017

Dongsik Park

22

1 reference

20 June 2017

Yoonae Ko

23

1 reference

20 June 2017

Inhee Choi

24

1 reference

20 June 2017

Ryangyeo Kim

25

1 reference

20 June 2017

Se Yeon Kim

26

1 reference

20 June 2017

SeungBin Lim

27

1 reference

20 June 2017

Seung-Ae Yim

28

1 reference

20 June 2017

Jiyoun Nam

29

1 reference

20 June 2017

Hwankyu Kang

30

1 reference

20 June 2017

Haejin Kwon

31

1 reference

20 June 2017

Chun-Taek Oh

32

1 reference

20 June 2017

Yoojin Cho

33

1 reference

20 June 2017

Yunhee Jang

34

1 reference

20 June 2017

Junghwan Kim

35

1 reference

20 June 2017

Adeline Chua

36

1 reference

20 June 2017

Bee Huat Tan

37

1 reference

20 June 2017

Mahesh B Nanjundappa

38

1 reference

20 June 2017

Srinivasa P S Rao

39

1 reference

20 June 2017

Whitney S Barnes

40

1 reference

20 June 2017

René Wintjens

41

1 reference

20 June 2017

John R Walker

42

1 reference

20 June 2017

Sylvie Alonso

43

1 reference

20 June 2017

Saeyeon Lee

44

1 reference

20 June 2017

Jungjun Kim

45

1 reference

20 June 2017

Soohyun Oh

46

1 reference

20 June 2017

Taegwon Oh

47

1 reference

20 June 2017

Ulf Nehrbass

48

1 reference

20 June 2017

Sung-Jun Han

49

1 reference

20 June 2017

Zaesung No

50

1 reference

20 June 2017

Jinhwa Lee

51

1 reference

20 June 2017

Priscille Brodin

52

1 reference

20 June 2017

Sang-Nae Cho

53

1 reference

20 June 2017

Kiyean Nam

54

1 reference

20 June 2017

Jaeseung Kim

55

1 reference

20 June 2017

language of work or name

English

0 references

publication date

4 August 2013

1 reference

20 June 2017

1 reference

20 June 2017

19

1 reference

20 June 2017

1157-1160

1 reference

20 June 2017

9

1 reference

Confronting multidrug-resistant tuberculosis

20 June 2017

1 reference

A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis

21 January 2018

1 reference

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

21 January 2018

1 reference

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis

21 January 2018

1 reference

Early bactericidal activity and pharmacokinetics of PA-824 in smear-positive tuberculosis patients

21 January 2018

1 reference

Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.

21 January 2018

1 reference

Delamanid for multidrug-resistant pulmonary tuberculosis

21 January 2018

1 reference

High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors

21 January 2018

1 reference

A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy

21 January 2018

1 reference

Identification of novel inhibitors of M. tuberculosis growth using whole cell based high-throughput screening.

21 January 2018

1 reference

Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism

21 January 2018

1 reference

Regiospecific synthesis of 3-substituted imidazo[1,2-a]pyridines, imidazo[1,2-a]pyrimidines, and imidazo[1,2-c]pyrimidine

21 January 2018

1 reference

The challenge of new drug discovery for tuberculosis

21 January 2018

1 reference

Fast standardized therapeutic-efficacy assay for drug discovery against tuberculosis

21 January 2018

1 reference

Activities of TMC207, rifampin, and pyrazinamide against Mycobacterium tuberculosis infection in guinea pigs

21 January 2018

1 reference

Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB

21 January 2018

1 reference

Function of the cytochrome bc1-aa3 branch of the respiratory network in mycobacteria and network adaptation occurring in response to its disruption

21 January 2018

1 reference

Genes required for mycobacterial growth defined by high density mutagenesis

21 January 2018

1 reference

Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity

21 January 2018

1 reference

A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating Mycobacterium tuberculosis

21 January 2018

1 reference

X-ray structure of the dimeric cytochrome bc(1) complex from the soil bacterium Paracoccus denitrificans at 2.7-Å resolution

21 January 2018

1 reference

Inhibitor-complexed structures of the cytochrome bc1 from the photosynthetic bacterium Rhodobacter sphaeroides

21 January 2018

1 reference

Structure at 2.3 A resolution of the cytochrome bc(1) complex from the yeast Saccharomyces cerevisiae co-crystallized with an antibody Fv fragment

21 January 2018

1 reference

Crystallographic studies of quinol oxidation site inhibitors: a modified classification of inhibitors for the cytochrome bc(1) complex

21 January 2018

1 reference

Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques

21 January 2018

1 reference

High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery

21 January 2018

1 reference

Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis

21 January 2018

1 reference

The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis

21 January 2018

1 reference

Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis

21 January 2018

1 reference

Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450

21 January 2018

1 reference

12 December 2020

National survey of drug-resistant tuberculosis in China

1 reference

12 December 2020

Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs.

1 reference

12 December 2020

Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3- hydroxy-1,4-naphthoquinone (566C80)

1 reference

12 December 2020

Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

1 reference

12 December 2020

Use of specific inhibitors on the mitochondrial bc1 complex

1 reference

12 December 2020

Identifiers

DOI

10.1038/NM.3262

1 reference

Dimensions Publication ID

20 June 2017

0 references

1 reference